Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Beach Point Capital Management LP | RPT Rithm Property Trust Inc. | 13G/A | 11% | Jan 31, 2024 | 2y |
| Bank of New York Mellon Corp | AIZ Assurant, Inc. | 13G/A | 4.22% | Jan 31, 2024 | 2y |
| GATE CITY CAPITAL MANAGEMENT, LLC | GEOS Geospace Technologies Corp | 13G/A | 0% | Jan 31, 2024 | 2y |
| JENNISON ASSOCIATES LLC | MBLY Mobileye Global Inc. | 13G/A | 0% | Jan 31, 2024 | 2y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | AEF abrdn Emerging Markets ex-China Fund, Inc. | 13G/A | 37.8% | Jan 31, 2024 | 2y |
| Bank of New York Mellon Corp | BAB Invesco Exchange-Traded Fund Trust II | 13G/A | 5.12% | Jan 31, 2024 | 2y |
| Bank of New York Mellon Corp | BSCA Invesco Exchange-Traded Self-Indexed Fund Trust | 13G/A | 43.01% | Jan 31, 2024 | 2y |
| AWM Investment Company, Inc. | SYNX Silynxcom Ltd. | 13G | 10% | Jan 31, 2024 | 2y |
| Dodge & Cox | AEG Aegon Ltd. | 13G/A | 10.9% | Jan 31, 2024 | 2y |
| EARNEST PARTNERS LLC | BOOM DMC Global Inc. | 13G/A | 0.6% | Jan 31, 2024 | 2y |
| MORGAN STANLEY | FPF First Trust Intermediate Duration Preferred & Income Fund | 13G/A | 10.1% | Jan 31, 2024 | 2y |
| Millennium Management LLC | CRBP Corbus Pharmaceuticals Holdings, Inc. | 13G | 4.1% | Jan 31, 2024 | 2y |
| MORGAN STANLEY | MRTX Mirati Therapeutics, Inc. Common Stock | 13G/A | 0% | Jan 31, 2024 | 2y |
| Bank of New York Mellon Corp | BSCA Invesco Exchange-Traded Self-Indexed Fund Trust | 13G/A | 9.85% | Jan 31, 2024 | 2y |
| Bank of New York Mellon Corp | ASHR DBX ETF Trust | 13G/A | 14.9% | Jan 31, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | TRIB Trinity Biotech PLC | 13D | 26.8% | Jan 30, 2024 | 2y |
| TCG Crossover GP I, LLC | CGON CG Oncology, Inc. | 13G | 5.4% | Jan 29, 2024 | 2y |
| TCG Crossover GP I, LLC | TRML Tourmaline Bio, Inc. Common Stock | 13G | 5.9% | Jan 29, 2024 | 2y |
| Dato' Sri Liew Kok Leong | ARBB ARB IOT Group Ltd | 13D | 14.73% | Jan 26, 2024 | 2y |
| S.H.N. Financial Investments Ltd. | CISS C3is Inc. | 13G | 5.2% | Jan 25, 2024 | 2y |
| Colonial House Capital Limited | EAF Graftech International Ltd | 13G | 9.7% | Jan 17, 2024 | 2y |
| SPRING CREEK CAPITAL LLC | LCW Learn CW Investment Corporation Class A Ordinary Shares | 13G | 5.25% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AGI Alamos Gold Inc | 13G/A | 8.3% | Dec 31, 2023 | 2y |
| Dennis H. Nelson | BKE Buckle Inc | 13G/A | 4.5% | Dec 31, 2023 | 2y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | JOF Japan Smaller Capitalization Fund Inc | 13G/A | 15.9% | Dec 31, 2023 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | FTII FutureTech II Acquisition Corp. | 13G | 8.45% | Dec 31, 2023 | 2y |
| Koller Capital LLC | MCHX Marchex Inc | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | TUP Tupperware Brands Corporation | 13G | 9.83% | Dec 31, 2023 | 2y |
| SPRING CREEK CAPITAL LLC | TRIS Tristar Acquisition I Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| BlackRock Inc. | BKR Baker Hughes Co | 13G | 5.2% | Dec 31, 2023 | 2y |
| Weiss Asset Management LP | THCP Thunder Bridge Capital Partners IV, Inc. Class A Common Stock | 13G/A | 6.45% | Dec 31, 2023 | 2y |
| Weiss Asset Management LP | MRT Marti Technologies, Inc. | 13G/A | 2.5% | Dec 31, 2023 | 2y |
| Martin Lorentzon | SPOT Spotify Technology S.A. | 13G/A | 10.9% | Dec 31, 2023 | 2y |
| Trigran Investments, Inc. | TTGT TechTarget, Inc. | 13G | 9.6% | Dec 31, 2023 | 2y |
| Blackstone Inc. | STR Sitio Royalties Corp. | 13G/A | 19.7% | Dec 31, 2023 | 2y |
| Artal Participations S.a r.l | APTX Aptinyx Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Saba Capital Management, L.P. | STET ST Energy Transition I Ltd. | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRINCIPAL FINANCIAL GROUP INC | FFNW First Financial Northwest, Inc | 13G/A | 8.8% | Dec 31, 2023 | 2y |
| Duanrong Liu | IZM ICZOOM Group Inc. | 13G | 24.4% | Dec 31, 2023 | 2y |
| Saba Capital Management, L.P. | PPHP PHP Ventures Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| BANK OF MONTREAL /CAN/ | FNVT Finnovate Acquisition Corp. Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| Castle Creek Capital Partners VI, LP | BCAL California BanCorp CA | 13G | 12.7% | Dec 31, 2023 | 2y |
| BROWN ADVISORY INC | INFN Infinera Corporation Common Stock | 13G/A | 6.5% | Dec 31, 2023 | 2y |
| Artal Participations S.a r.l | NBTX Nanobiotix S.A. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Blackstone Holdings II L.P. | CRBG Corebridge Financial, Inc. | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| MORGAN STANLEY | TARS Tarsus Pharmaceuticals, Inc. | 13G | 5.9% | Dec 31, 2023 | 2y |
| BROWN ADVISORY INC | BFAM Bright Horizons Family Solutions Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Polar Asset Management Partners Inc. | ASCA A SPAC I Acquisition Corp. Class A Ordinary Share | 13G/A | 2.7% | Dec 31, 2023 | 2y |
| PRINCIPAL FINANCIAL GROUP INC | EBC Eastern Bankshares, Inc. | 13G/A | 8.45% | Dec 31, 2023 | 2y |
| Robert Nelsen | SANA Sana Biotechnology, Inc. | 13G/A | 22.4% | Dec 31, 2023 | 2y |